Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 71335-2691

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 71335-2691). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352691)

Label (Lbl713352691)
This text provides information on a medication containing Quetiapine Fumarate USP equivalent to 50 mg of Quetiapine. The film-coated tablets are suitable for adult dosages. The warning advises to keep the tablets out of reach of children. The storage instructions recommend storing the tablets at 25°C (77°F) with permissible excursions between 15° to 30°C (59° to 86°F). The NDC code for the tablets is 71335-2691-1. Further dosage details and packaging information are available in the package insert, which can be accessed through a QR code. The medication is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Aurobindo Pharma Limited.*
FDA Label Image

Figure1 (Quetiapine Fig1)

Figure1 (Quetiapine Fig1)
This text provides information about the proportion of patients experiencing a relapse and includes a figure showing Kaplan-Meier curves depicting the time to recurrence of a mood event in Study 7.*
FDA Label Image

Figure2 (Quetiapine Fig2)

FDA Label Image

Chemical Structure (Quetiapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.